Clinical Trial Update: Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on stem cell transplantation from partially HLA-m matched related donors for hematologic malignancies; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Snippet

Sponsor: Northwell Health | Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Phase 3 | Status: COMPLETED